Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma.

[1]  A. Rosenwald,et al.  t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2 , 2011, Genes, chromosomes & cancer.

[2]  R. Young,et al.  The Msx1 Homeoprotein Recruits Polycomb to the Nuclear Periphery during Development. , 2011, Developmental cell.

[3]  Steven J. M. Jones,et al.  Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.

[4]  H. Drexler,et al.  Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia , 2011, Leukemia & lymphoma.

[5]  K. Wright,et al.  Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas. , 2011, Blood.

[6]  Ulf Leser,et al.  Classical Hodgkin’s lymphoma shows epigenetic features of abortive plasma cell differentiation , 2011, Haematologica.

[7]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[8]  H. Drexler,et al.  Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia , 2011, Leukemia & lymphoma.

[9]  I. Su,et al.  Dominant expression of survival signals of endoplasmic reticulum stress response in Hodgkin lymphoma , 2011, Cancer science.

[10]  Guillaume J. Filion,et al.  Systematic Protein Location Mapping Reveals Five Principal Chromatin Types in Drosophila Cells , 2010, Cell.

[11]  G. Morgan,et al.  XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. , 2010, Blood.

[12]  H. Drexler,et al.  Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. , 2010, Leukemia research.

[13]  T. Kooistra,et al.  An Essential Role for XBP-1 in Host Protection against Immune Activation in C. elegans , 2010, Nature.

[14]  H. Drexler,et al.  NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells , 2009, BMC Cancer.

[15]  M. Beato,et al.  Histone H1 Subtypes Differentially Modulate Chromatin Condensation without Preventing ATP-Dependent Remodeling by SWI/SNF or NURF , 2009, PloS one.

[16]  W. Klapper,et al.  TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma , 2009, The Journal of experimental medicine.

[17]  G. Tate,et al.  A novel missense mutation of the XBP1 gene in diffuse large B-cell lymphoma. , 2009, Cancer genetics and cytogenetics.

[18]  Thomas L. Dunwell,et al.  Epigenetic analysis of childhood acute lymphoblastic leukemia , 2009, Epigenetics.

[19]  G. Spyrou,et al.  ERdj5 Sensitizes Neuroblastoma Cells to Endoplasmic Reticulum Stress-induced Apoptosis* , 2009, Journal of Biological Chemistry.

[20]  D. Doenecke,et al.  Histone H1 and its isoforms: contribution to chromatin structure and function. , 2009, Gene.

[21]  Peter Möller,et al.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. , 2009, Neoplasia.

[22]  R. Hardy,et al.  Pax5 and Linker Histone H1 Coordinate DNA Methylation and Histone Modifications in the 3′ Regulatory Region of the Immunoglobulin Heavy Chain Locus , 2008, Molecular and Cellular Biology.

[23]  A. Órfão,et al.  Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma , 2008, British journal of haematology.

[24]  H Stein,et al.  Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype , 2008, Leukemia.

[25]  E. Giné,et al.  Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment , 2008, Haematologica.

[26]  Inge Jonassen,et al.  Characterization of Early Stages of Human B Cell Development by Gene Expression Profiling1 , 2007, The Journal of Immunology.

[27]  A. Rosenwald,et al.  Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. , 2007, Blood.

[28]  H. Drexler,et al.  Cytogenetic harvesting of commonly used tumor cell lines , 2007, Nature Protocols.

[29]  R. Siebert,et al.  Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses. , 2006, Cancer genetics and cytogenetics.

[30]  A. Koong,et al.  Targeting XBP-1 as a novel anti-cancer strategy , 2006, Cancer biology & therapy.

[31]  J. Callahan,et al.  The Arf-family protein, Arl8b, is involved in the spatial distribution of lysosomes. , 2006, Biochemical and biophysical research communications.

[32]  H. Stein,et al.  Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma , 2006, Nature Immunology.

[33]  N. Agnantis,et al.  B-cell differentiation immunophenotypes in classical Hodgkin lymphomas , 2006, Leukemia & lymphoma.

[34]  A. Stein,et al.  Histone H1 Depletion in Mammals Alters Global Chromatin Structure but Causes Specific Changes in Gene Regulation , 2005, Cell.

[35]  B. Robert,et al.  msh/Msx gene family in neural development. , 2005, Trends in genetics : TIG.

[36]  Kazuya Yamada,et al.  Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. , 2005, Frontiers in bioscience : a journal and virtual library.

[37]  H. Jäck,et al.  Evidence of abortive plasma cell differentiation in Hodgkin and Reed‐Sternberg cells of classical Hodgkin lymphoma , 2005, Hematological oncology.

[38]  H. Quentmeier,et al.  HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3 , 2005, Leukemia.

[39]  Alla V. Ivanova,et al.  STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets. , 2004, Journal of molecular biology.

[40]  L. Staudt,et al.  XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. , 2004, Immunity.

[41]  R. Habas,et al.  Msx1 Cooperates with Histone H1b for Inhibition of Transcription and Myogenesis , 2004, Science.

[42]  Seiji Okada,et al.  Impaired lymphocyte development and function in Clast5/Stra13/DEC1‐transgenic mice , 2004, European journal of immunology.

[43]  Y. Tsujimoto,et al.  Involvement of Histone H1.2 in Apoptosis Induced by DNA Double-Strand Breaks , 2003, Cell.

[44]  K. Rajewsky,et al.  Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1 , 2003, Nature Immunology.

[45]  M. Höglund,et al.  A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age‐ and sex‐related differences , 2003, British journal of haematology.

[46]  Hiderou Yoshida,et al.  A time-dependent phase shift in the mammalian unfolded protein response. , 2003, Developmental cell.

[47]  B. Owens,et al.  HOX and Non‐HOX Homeobox Genes in Leukemic Hematopoiesis , 2002, Stem cells.

[48]  Seiji Okada,et al.  Clast5/Stra13 is a negative regulator of B lymphocyte activation. , 2002, Biochemical and biophysical research communications.

[49]  K. Mori,et al.  XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor , 2001, Cell.

[50]  R. Flavell,et al.  Defective T cell activation and autoimmune disorder in Stra13-deficient mice , 2001, Nature Immunology.

[51]  C. Murre,et al.  The role of E2A-PBX1 in leukemogenesis , 2001, Oncogene.

[52]  T. Kawamoto,et al.  Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway. , 2001, European journal of cell biology.

[53]  H. Stein,et al.  Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. , 2001, Blood.

[54]  C. Abate-Shen,et al.  Roles for Msx and Dlx homeoproteins in vertebrate development. , 2000, Gene.

[55]  E. Macintyre,et al.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease , 1999, Leukemia.

[56]  B. Johansson,et al.  Deletion of chromosome arm 3p in hematologic malignancies , 1997, Leukemia.

[57]  D. Davidson,et al.  The function and evolution of Msx genes: pointers and paradoxes. , 1995, Trends in genetics : TIG.

[58]  Michael Wolfe,et al.  J+ = J , 1994, ACM SIGPLAN Notices.

[59]  Ralf Küppers,et al.  The biology of Hodgkin's lymphoma , 2009, Nature Reviews Cancer.

[60]  G. Spyrou,et al.  1 ERdj 5 sensitizes neuroblastoma cells to endoplasmic reticulum stress-induced apoptosis , 2008 .

[61]  M. Lerman,et al.  STRA 13 Interacts with STAT 3 and Modulates Transcription of STAT 3-dependent Targets , 2004 .

[62]  S. Pileri,et al.  Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. , 2004, Blood.

[63]  清宮 美香,et al.  Clast5/Stra13 is a negative regulator of B lymphocyte activation , 2003 .

[64]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[65]  C. Shen.  DEREGULATED HOMEOBOX GENE EXPRESSION IN CANCER: CAUSE OR CONSEQUENCE? , 2002 .

[66]  D. Duboule.  Guidebook to the homeobox genes , 1994 .